Redmile Group, LLC

The estimated Net Worth of Redmile Group, LLC is at least $1241 Million dollars dollars as of 10/21/2021. Redmile Group, LLC is the 10% Owner of Neoleukin Therapeutics Inc. Redmile Group, LLC owns over 4,041,211 shares of Neoleukin Therapeutics Inc stock worth over $28 Million dollars . Redmile Group, LLC is the Director, 10% Owner of Fate Therapeutics Inc. Redmile Group, LLC owns over 12,957,222 shares of Fate Therapeutics Inc stock worth over $771 Million dollars . Redmile Group, LLC is the 10% Owner of Amicus Therapeutics Inc. Redmile Group, LLC owns over 12,956,446 shares of Amicus Therapeutics Inc stock worth over $136 Million dollars . Redmile Group, LLC is the 10% Owner of Syros Pharmaceuticals Inc. Redmile Group, LLC owns over 49,793 shares of Syros Pharmaceuticals Inc stock worth over $215,105.76. Redmile Group, LLC is the 10% Owner of Xeris Biopharma Holdings Inc. Redmile Group, LLC owns over 3,000,642 shares of Xeris Biopharma Holdings Inc stock worth over $6 Million dollars . Redmile Group, LLC is the Director, 10% Owner of IGM Biosciences Inc. Redmile Group, LLC owns over 3,425,811 shares of IGM Biosciences Inc stock worth over $182 Million dollars . Redmile Group, LLC is the 10% Owner of Aprea Therapeutics Inc. Redmile Group, LLC owns over 1,768,718 shares of Aprea Therapeutics Inc stock worth over $9 Million dollars . Redmile Group, LLC is the Director, 10% Owner of Shattuck Labs Inc. Redmile Group, LLC owns over 5,619,914 shares of Shattuck Labs Inc stock worth over $108 Million dollars .

Redmile Group, LLC mailing address: ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129

Insider Roles

Name Transaction Date Position
Shattuck Labs Inc 2020-10-14 director, 10 percent owner
IGM Biosciences Inc 2020-10-01 director, 10 percent owner
Kymera Therapeutics Inc 2020-08-25 10 percent owner
AlloVir Inc 2020-08-03 10 percent owner
Annexon Inc 2020-07-28 10 percent owner
Nurix Therapeutics Inc 2020-07-28 10 percent owner
Repare Therapeutics Inc 2020-06-23 10 percent owner
Fate Therapeutics Inc 2020-06-11 director, 10 percent owner
Pliant Therapeutics Inc 2020-06-05 10 percent owner
Neoleukin Therapeutics Inc 2020-03-27 10 percent owner
Beam Therapeutics Inc 2020-02-10 10 percent owner
Cabaletta Bio Inc 2019-10-29 10 percent owner
Alder BioPharmaceuticals Inc 2019-10-22 director
Aprea Therapeutics Inc 2019-10-07 10 percent owner
Atreca Inc 2019-06-24 10 percent owner
Akero Therapeutics Inc 2019-06-24 10 percent owner
Stoke Therapeutics Inc 2019-06-21 10 percent owner
HOOKIPA Pharma Inc 2019-04-23 10 percent owner
Xeris Biopharma Holdings Inc 2019-02-19 10 percent owner
TCR2 Therapeutics Inc 2019-02-19 10 percent owner
Vapotherm Inc 2018-11-16 10 percent owner
Gritstone Bio Inc 2018-10-02 10 percent owner
Replimune Group Inc 2018-07-24 10 percent owner
Allakos Inc 2018-07-23 10 percent owner
Syros Pharmaceuticals Inc 2016-07-06 10 percent owner
Amicus Therapeutics Inc 2016-06-03 10 percent owner
EMBED
SAVE

Redmile Group, LLC trading performance

Average Relative Return

47.94%

Average relative return per transaction

Outperforming Transactions

71%

12 out of 17 outperforming transactions.
Each transaction is measured over a period and compared to .

Redmile Group, LLC trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 2.57 7.76 -1.1 47.94 141.04 210.25
Relative Return to S&P 500(%) 1.36 1.98 -4.21 34.7 111.38 168.58

Redmile Group, Llc trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
ADGI
Adagio Therapeutics Inc
$33.65
Redmile Group, LLC
10% Owner
2021-08-10 Buy
1,470,000
76.52%
$17
$24,990
3,390,960
97.94%
0
At Loss
3,743.62
ABSI
Absci Corp
$11.86
Redmile Group, LLC
Director
2021-07-26 Buy
1,875,000
30.46%
$16
$30,000
8,031,094
-25.88%
0
At Loss
1,097.73
VERV
Verve Therapeutics Inc
$43.97
Redmile Group, LLC
10% Owner
2021-06-21 Buy
1,050,000
118.44%
$19
$19,950
1,936,530
131.42%
0
At Loss
2,110.20
FATE
Fate Therapeutics Inc
$59.48
Redmile Group, LLC
Director, 10% Owner
2021-01-08 Buy
327,485
2.59%
$85.50
$28,000
12,957,222
-30.43%
0
At Loss
5,661.58
APRE
Aprea Therapeutics Inc
$5.11
Redmile Group, LLC
10% Owner
2020-12-28 Sell
500,000
-22.04%
$5.58
$2,790
1,768,718
-8.42%
0
At Loss
108.27
STTK
Shattuck Labs Inc
$19.28
Redmile Group, LLC
Director, 10% Owner
2020-10-14 Buy
3,441,176
157.94%
$17.34
$59,670
5,619,914
11.19%
0
At Loss
812.13
N/A
N/A
N/A3
Redmile Group, LLC
Director, 10% Owner
2020-10-05 Buy
5,000,000
64.47%
N/A3
N/A
12,755,327
0%
N/A
N/A
N/A
IGMS
IGM Biosciences Inc
$53.21
Redmile Group, LLC
Director, 10% Owner
2020-09-09 Buy
144,806
4.41%
$50.52
$7,315.60
3,425,811
5.32%
0
At Loss
1,706.03
IGMS
IGM Biosciences Inc
$53.21
Redmile Group, LLC
Director, 10% Owner
2020-09-03 Buy
136,649
4.35%
$47.21
$6,451.20
3,281,005
12.71%
0
At Loss
1,706.03
FATE
Fate Therapeutics Inc
$59.48
Redmile Group, LLC
Director, 10% Owner
2020-06-11 Buy
1,412,928
12.60%
$28.31
$40,000
12,629,737
110.10%
0
At Loss
5,661.58
NLTX
Neoleukin Therapeutics Inc
$7.01
Redmile Group, LLC
10% Owner
2020-04-02 Sell
19,668
-0.48%
$11.19
$220.09
4,041,211
-37.35%
0
At Loss
297.40
NLTX
Neoleukin Therapeutics Inc
$7.01
Redmile Group, LLC
10% Owner
2020-04-02 Buy
194,300
5.05%
$10.35
$2,011.01
4,041,211
-32.27%
0
At Loss
297.40
APRE
Aprea Therapeutics Inc
$5.11
Redmile Group, LLC
10% Owner
2019-10-07 Buy
400,000
21.41%
$15
$6,000
2,268,718
-65.93%
0
At Loss
108.27
FATE
Fate Therapeutics Inc
$59.48
Redmile Group, LLC
Director, 10% Owner
2019-09-16 Buy
857,143
8.27%
$17.50
$15,000
11,216,809
239.89%
0
At Loss
5,661.58
XERS
Xeris Biopharma Holdings Inc
$1.97
Redmile Group, LLC
10% Owner
2019-02-19 Buy
588,000
24.37%
$10
$5,880
3,000,642
-80.30%
0
At Loss
245.46
FATE
Fate Therapeutics Inc
$59.48
Redmile Group, LLC
Director, 10% Owner
2018-09-25 Buy
3,703,704
55.64%
$13.50
$50,000
10,359,666
340.59%
0
At Loss
5,661.58
XERS
Xeris Biopharma Holdings Inc
$1.97
Redmile Group, LLC
10% Owner
2018-06-25 Buy
666,668
38.18%
$15
$10,000
2,412,642
-86.87%
0
At Loss
245.46
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2016-09-28 Sell
2,492,578
-13.02%
$6.36
$15,852.80
16,658,072
512.42%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2016-09-15 Sell
400,000
-2.05%
$3.50
$1,400
19,150,650
1,012.86%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2016-09-15 Buy
400,000
2.13%
$3.51
$1,404
19,150,650
1,009.69%
0
At Loss
8,689.56
SYRS
Syros Pharmaceuticals Inc
$4.32
Redmile Group, LLC
10% Owner
2016-07-06 Buy
432,746
0%
$12.50
$5,409.32
49,793
-65.44%
0
At Loss
267.54
FOLD
Amicus Therapeutics Inc
$10.52
Redmile Group, LLC
10% Owner
2016-06-03 Buy
66,300
0.51%
$7.20
$477.36
12,956,446
46.11%
0
At Loss
2,811.86
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2016-01-20 Buy
300,000
1.59%
$3.19
$957
19,150,650
1,121%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2016-01-12 Buy
75,000
0.40%
$3.60
$270
18,850,650
981.94%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2016-01-11 Buy
925,000
5.18%
$3.67
$3,394.75
18,775,650
961.31%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2015-10-01 Buy
600,140
3.48%
$4.58
$2,748.64
17,850,650
750.44%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2015-10-01 Buy
782,592
4.54%
$4.58
$3,584.27
18,033,102
750.44%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2015-08-26 Buy
49,900
0.29%
$5.48
$273.45
17,250,510
610.77%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2015-08-25 Buy
790,000
4.81%
$5.38
$4,250.20
17,200,610
623.98%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2015-08-12 Buy
532,500
1.66%
$5.88
$3,131.10
32,616,220
562.41%
0
At Loss
8,689.56
DELISTED:ARRY
Array BioPharma Inc
$38.95
Redmile Group, LLC
10% Owner
2015-08-10 Buy
1,048,993
7.07%
$5.80
$6,084.16
15,878,110
571.55%
0
At Loss
8,689.56
Total 31
  • 1

Redmile Group, LLC personal network

Name Position Linked company